REDHILL BIOPHARMA LTD-SP ADR (RDHL)       0.9891  +0.06 (+6.3%)

0.9891  +0.06 (+6.3%)

US7574681034 - ADR - After market: 0.988 0 (-0.11%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q1 2022 -0.30 -0.23 -0.07-27.88% Q4 2021 -0.50 -0.34 -0.16-48.54% Q3 2021 -0.50 -0.21 -0.29-137.19% Q2 2021 -0.60 -0.12 -0.48-398.50% Q1 2021 -0.50 -0.35 -0.15-44.18% Q4 2020 -0.70 -0.25 -0.45-183.00% Q3 2020 -0.50 -0.16 -0.34-210.25% Q2 2020 -0.40 -0.07 -0.33-460.22%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.93 -2.10 55.92%Q2 2022 -0.03 -0.60 94.90%Q3 2022 -0.03 -0.50 93.88%Q4 2022 -0.03 -0.50 93.88%FY 2023 -0.39 -0.93 57.58%FY 2024 0.14 -0.39 136.36%FY 2025 0.06 0.14 -61.38%FY 2026 0.02 0.06 -60.61%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q1 2022 18.236M 24.786M -6.55M-26.43% Q4 2021 22.071M 24.559M -2.488M-10.13% Q3 2021 21.609M 25.011M -3.402M-13.60% Q2 2021 21.502M 25.522M -4.02M-15.75% Q1 2021 20.58M 23.157M -2.577M-11.13% Q4 2020 21.46M 26.555M -5.095M-19.19% Q3 2020 20.94M 25.879M -4.939M-19.09% Q2 2020 20.9M 23.45M -2.55M-10.87%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 107.317M 85.757M 25.14%Q2 2022 21.933M 21.502M 2.00%Q3 2022 23.653M 21.609M 9.46%Q4 2022 25.954M 22.071M 17.59%FY 2023 175.236M 107.317M 63.29%FY 2024 307.224M 175.236M 75.32%FY 2025 509.945M 307.224M 65.98%FY 2026 863.359M 509.945M 69.30%